SSA
TIL icon

Schonfeld Strategic Advisors’s Instil Bio TIL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,864
Closed -$241K – 2540
2025
Q1 		$241K Buy
+13,864
New +$288K ﹤0.01% 1879
2022
Q3 		– Sell
-580
Closed -$53K – 3163
2022
Q2 		$53K Buy
+580
New +$82.1K ﹤0.01% 2215

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Schonfeld Strategic Advisors's TIL Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Instil Bio (TIL) in Q2 2025, closing a stake of 13,864 shares — an estimated $241K sold.

Schonfeld Strategic Advisors first reported a position in TIL in Q2 2022 and held it in 2 quarters. The position peaked at $241K in Q1 2025. 38 funds tracked by Wall St. Rank hold TIL as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Instil Bio position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,864 Instil Bio shares in Q2 2025, an estimated $241K.
  • Schonfeld Strategic Advisors first reported a position in Instil Bio in Q2 2022 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Instil Bio position peaked at $241K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Instil Bio as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.